Preclinical Alzheimer's disease

被引：1
|
作者：
Gil-Gregorio, P. [1 ]
Yubero-Pancorbo, R. [1 ]
机构：
[1] Hosp Clin San Carlos, Dept Geriatr, Memory Unit, Madrid, Spain
来源：
REVIEWS IN CLINICAL GERONTOLOGY | 2014年 / 24卷 / 02期
关键词：
Alzheimer's disease; preclinical stages; amyloidosis; neurodegeneration; cognition;
D O I：
10.1017/S095925981400001X
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Recently, diagnostic criteria for preclinical Alzheimer's disease have been proposed. These describe and define three stages of disease. Stage I is focused on asymptomatic cerebral amyloidosis. Stage II includes evidence of synaptic dysfunction and/or early degeneration. Finally, stage III of the disease is characterized by the beginning of cognitive decline.
引用
收藏
页码：117 / 121
页数：5
相关论文
共 50 条
  • [1] Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease
    Ho, Jean K.
    Nation, Daniel A.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2018, 24 (07) : 693 - 702
  • [2] Cognitive deficits in preclinical Alzheimer's disease
    Small, BJ
    Mobly, JL
    Laukka, EJ
    Jones, S
    Bäckman, L
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 : 29 - 33
  • [3] Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease
    Keleman, Audrey A.
    Nicosia, Jessica y
    Bollinger, Rebecca M.
    Wisch, Julie K.
    Hassenstab, Jason
    Morris, John C.
    Ances, Beau M.
    Balota, David A.
    Stark, Susan L.
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 739 - 750
  • [4] Preclinical Alzheimer's Disease Therapeutics
    Rafii, Michael S.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S545 - S549
  • [5] Biomarkers in preclinical Alzheimer's disease
    Chong, Mei Sian
    Lim, Wee Shiong
    Sahadevan, Suresh
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (07) : 600 - 607
  • [6] Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers
    Mendes, Aline
    du Montcel, Sophie Tezenas
    Levy, Marcel
    Bertrand, Anne
    Habert, Marie-Odile
    Bertin, Hugo
    Dubois, Bruno
    Epelbaum, Stephane
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 45 (5-6) : 272 - 281
  • [7] Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
    Chatterjee, Pratishtha
    Pedrini, Steve
    Ashton, Nicholas J.
    Tegg, Michelle
    Goozee, Kathryn
    Singh, Abhay K.
    Karikari, Thomas K.
    Simren, Joel
    Vanmechelen, Eugeen
    Armstrong, Nicola J.
    Hone, Eugene
    Asih, Prita R.
    Taddei, Kevin
    Dore, Vincent
    Villemagne, Victor L.
    Sohrabi, Hamid R.
    Zetterberg, Henrik
    Masters, Colin L.
    Blennow, Kaj
    Martins, Ralph N.
    ALZHEIMERS & DEMENTIA, 2022, 18 (06) : 1141 - 1154
  • [8] An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
    Khan, Tapan K.
    FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [9] Depressive symptoms and preclinical Alzheimer's disease
    Bidzan, Leszek
    Bidzan, Mariola
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2005, 7 (03): : 13 - 17
  • [10] Pathology of clinical and preclinical Alzheimer’s disease
    Dietmar Rudolf Thal
    Christine von Arnim
    W. Sue T. Griffin
    Haruyasu Yamaguchi
    Robert E. Mrak
    Johannes Attems
    Ajeet Rijal Upadhaya
    European Archives of Psychiatry and Clinical Neuroscience, 2013, 263 : 137 - 145
12345